Metzl brings unique perspective to study of humanities and medicine
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic "signature" from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.
After a decade of work, Vanderbilt scientists have received the green light to take a novel drug to the next step in humans.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: